Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether tamsulosin reduces postoperative urinary retention after pelvic reconstructive surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: Urinary Retention Postoperative | Phase 2 | Status: RECRUITING